oxophenylarsine has been researched along with arsenic trioxide in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fichtl, B; Hunder, G; Nguyen, PT; Schümann, K | 1 |
Chaudhary, PM; Matta, H; Sun, Q | 1 |
Chen, CH; Chen, TC; Jan, KY; Lin, SY; Samikkannu, T; Wang, AS; Yih, LH | 1 |
Brown, AM; Dennis, AT; Ficker, E; Hawryluk, P; Kuryshev, YA; Obejero-Paz, C; Wang, L; Wible, BA | 1 |
Hayash, H; Horii, T; Kitamura, K; Kobayashi, M; Maekawa, M; Naito, K; Nakamura, S; Naoe, T; Ohnishi, K; Ohno, R; Sahara, N; Shigeno, K; Shinjo, K; Takeshita, A | 1 |
Beachy, PA; Gardner, D; Kim, J; Lee, JJ | 1 |
6 other study(ies) available for oxophenylarsine and arsenic trioxide
Article | Year |
---|---|
Influence of inorganic and organic arsenicals on intestinal transfer of nutrients.
Topics: Animals; Arsenic; Arsenic Trioxide; Arsenicals; Body Water; Dose-Response Relationship, Drug; Glucose; Intestinal Mucosa; Jejunum; Leucine; Male; Oxides; Rats; Rats, Sprague-Dawley; Sodium | 1993 |
The human herpes virus 8-encoded viral FLICE inhibitory protein protects against growth factor withdrawal-induced apoptosis via NF-kappa B activation.
Topics: Acetylcysteine; Acute Disease; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-X Protein; Cell Transformation, Viral; Enzyme Activation; Gene Expression Regulation, Viral; Granulocyte-Macrophage Colony-Stimulating Factor; Herpesvirus 8, Human; Humans; I-kappa B Proteins; Leukemia, Myeloid; Leupeptins; Mitochondria; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; NF-kappa B; Oxides; Proto-Oncogene Proteins c-bcl-2; Recombinant Fusion Proteins; Recombinant Proteins; Rhadinovirus; Transcription, Genetic; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Viral Proteins | 2003 |
Reactive oxygen species are involved in arsenic trioxide inhibition of pyruvate dehydrogenase activity.
Topics: Animals; Antioxidants; Arsenic Trioxide; Arsenicals; Chelating Agents; Copper Sulfate; Enzyme Inhibitors; Ferrous Compounds; HL-60 Cells; Humans; Hydrogen Peroxide; Inhibitory Concentration 50; Mitochondria, Heart; Myocardium; NADPH Oxidases; Oxides; Pyruvate Dehydrogenase Complex; Reactive Oxygen Species; Sulfhydryl Compounds; Swine | 2003 |
Mechanisms of arsenic-induced prolongation of cardiac repolarization.
Topics: Animals; Arsenic Trioxide; Arsenicals; Calcium; Electrophysiology; Enzyme Inhibitors; Guinea Pigs; Heart; Heart Ventricles; Humans; Myocytes, Cardiac; Oxides; Potassium Channels | 2004 |
Phenylarsine oxide (PAO) more intensely induces apoptosis in acute promyelocytic leukemia and As2O3-resistant APL cell lines than As2O3 by activating the mitochondrial pathway.
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; bcl-X Protein; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Dose-Response Relationship, Drug; Down-Regulation; Drug Resistance, Neoplasm; Humans; Leukemia, Promyelocytic, Acute; Membrane Potentials; Mitochondria; Oxides; Proto-Oncogene Proteins c-bcl-2 | 2004 |
Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector.
Topics: Animals; Arsenic Trioxide; Arsenicals; Arsenites; Cerebellar Neoplasms; Dose-Response Relationship, Drug; Hedgehog Proteins; Kruppel-Like Transcription Factors; Luciferases; Luminescent Proteins; Medulloblastoma; Mice; Mice, Knockout; Mice, Nude; Neoplasms, Experimental; NIH 3T3 Cells; Oxides; Protein Stability; Recombinant Fusion Proteins; Signal Transduction; Sodium Compounds; Transfection; Transplantation, Homologous; Tumor Suppressor Protein p53; Zinc Finger Protein Gli2 | 2010 |